KINGDON CAPITAL

kingdon-capital-logo

Kingdon Capital Management, L.L.C. is an employee owned hedge fund sponsor. The firm provides its services to high net worth individuals and institutional clients. It invests in the public equity, fixed income, and alternative investment markets across the globe. The firm invests in growth and value stocks of all-cap companies. It also invests in currency futures and options and long/short strategies to hedge its client's risks. It employs a top-down approach to select the economies and fundamental and technical analysis with a bottom-up stock picking approach to make investments. The firm conducts in-house research to make its investments. Kingdon Capital Management was founded in 1983 and is based in New York City.

#People #Financial #More

KINGDON CAPITAL

Founded:
1983-01-01

Status:
Active

Email Addresses:
[email protected]

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Domain Not Resolving Apache Wordpress Plugins PHP


Current Employees Featured

not_available_image

Mark E. Kingdon
Mark E. Kingdon President, CEO/Managing Member & Founder @ Kingdon Capital
President, CEO/Managing Member & Founder

Founder


not_available_image

Mark E. Kingdon

Investments List

Date Company Article Money raised
2022-05-31 Sapience Therapeutics Kingdon Capital investment in Series B - Sapience Therapeutics 41 M USD
2021-11-02 Shoreline Biosciences Kingdon Capital investment in Series B - Shoreline Biosciences 140 M USD
2021-09-27 Jasper Therapeutics Kingdon Capital investment in Post-IPO Equity - Jasper Therapeutics 100 M USD
2021-04-13 CeQur Kingdon Capital investment in Series C - CeQur 115 M USD
2020-11-19 Imago BioSciences Kingdon Capital investment in Series C - Imago BioSciences 80 M USD
2019-12-05 Athenex Kingdon Capital investment in Post-IPO Equity - Athenex 60 M USD
2018-06-18 Stealth BioTherapeutics Kingdon Capital investment in Convertible Note - Stealth BioTherapeutics 100 M USD
2017-04-23 SteadyMed Therapeutics Kingdon Capital investment in Post-IPO Equity - SteadyMed Therapeutics 30 M USD
2017-01-03 Napo Pharmaceuticals Kingdon Capital investment in Debt Financing - Napo Pharmaceuticals 2 M USD
2007-05-25 Mformation Technologies Kingdon Capital investment in Series E - Mformation Technologies 20 M USD

More informations about "Kingdon Capital" on Search Engine